NTI | bio Partners with Carnegie India for the 2022 Global Tech Summit as India Assumes the G20 Presidency

Carnegie India, in collaboration with India’s Ministry of External Affairs, hosted the 7th  annual Global Technology Summit on November 29-December 1 in New Delhi. The summit featured more than 100 experts and senior-level speakers, including an opening address and conversation with Dr. S. Jaishankar, External Affairs Minister of India. NTI was one of four official “Knowledge Partners” for the event.

NTI | bio partnered with Carnegie India on a closed-door roundtable discussion entitled, “Safeguarding Biotechnology Innovation and Boosting Global Bioeconomy: The Road to G20.” NTI Vice President for Global Biological Policy and Programs Dr. Jaime Yassif was also a featured panelist in a public plenary session called, “Architecture for Global Biosafety and Biosecurity.”  Yassif appeared alongside Dr. Piers Millett, the inaugural executive director of the International Biosecurity and Biosafety Initiative for Science (IBBIS), as well as Indian biosecurity expert Dr. Mrinmayee Bhushan.

Yassif and Millett discussed NTI’s ongoing effort with global partners to launch IBBIS, a new international organization focused on reducing emerging biological risks associated with rapid technology advances. The panelists also discussed India’s opportunity, as it assumes the G20 presidency, to make biosecurity, biosafety, and biotechnology governance a priority on their G20 agenda.

NTI-led events at the Global Technology Summit brought together representatives from government, industry, academia, and civil society to discuss biosafety and biosecurity challenges as well as practical solutions to address emerging risks. Both sessions highlighted the potential benefits of biotechnology innovation, while acknowledging the growing risks of accidents or deliberate misuse of these emerging technologies—especially in the absence of adequate safeguards.

NTI | bio will continue to work with Carnegie India on the practical ideas raised in these discussions to strengthen global biosecurity and biosafety so biotechnology can flourish, safely and responsibly.